Articles Tagged: Stem Cells
Published: February 12, 2013 | Category:
News StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant
NEWARK, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced that the twelve-month data from the first patient cohort in the Company’s Phase I/II clinical trial of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. Continue Reading »
Published: September 25, 2012 | Category:
News 
European researchers have made significant progress in the attempt to treat spinal cord injuries using stem cell therapy. Although there have been several attempt to cure spinal cord injury patients, the results were not so encouraging.
Now, however, the project “From stem cell technology to functional restoration after spinal cord injury ‘(Rescue) has promising results so far. Continue Reading »
Published: September 7, 2012 | Category:
News 
(CNN) — As the sun rose over France on August 13, 2011, Knut Olstad was looking forward to continuing his bicycle journey along the Tour de France route. But by the end of the day, the vacation had taken a terrible turn that would change his life.
The 46-year-old financial consultant from Norway doesn’t remember much about the accident that left him paralyzed from the chest down. He was shown pictures of himself lying on the ground with a broken back after being catapulted from his bike while trying to avoid a collision with a car. Continue Reading »
Published: August 23, 2012 | Category:
News After 26 years in a wheel chair William Orr is walking. It is with the assistance of a walker, but he is walking. Orr is walking to get his mail, he is walking to rehab from his car and he is planning on walking into his 35th high school reunion.
After 26 years in a wheel chair William Orr is walking. Granted it is with the assistance of a walker, but he is walking. Orr is walking to get his mail, he is walking to rehab from his parked car and he is planning on walking into his 35th high school reunion. Continue Reading »
Published: May 17, 2012 | Category:
News Thirty Percent of Patients Show Improved Functioning after Stem Cell Therapy
Philadelphia, Pa. (May 17, 2012) – One of the first long-term studies of stem cell treatment for spinal cord injury shows significant functional and other improvements in three out of ten patients, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Continue Reading »
Given that the firm with the most money has just quit, questions about how to succeed are rampant.
Geron, a pioneer in stem cell research founded in 1990, announced on November 14 that it was halting its stem cell therapeutics programs to conserve funds. It plans on laying off 38% of its 175-person staff and is seeking partners to take on the programs’ assets.
Geron had been developing cell products from differentiated human embryonic stem cells (hESCs) for multiple indications. The company is viewed as the leader in stem cell therapies because of its patents on technology used to grow, manipulate, and inject stem cells into the human body. It helped finance researchers at the University of Wisconsin who first isolated human embryonic stem cells in 1998, allowing the cells to be grown in the laboratory. Continue Reading »
A District Court judge in the US has dismissed a lawsuit that sought to ban federal funding for human embryonic stem cell (hESC) research. The decision, by Judge Royce Lambeth, is the latest development in the case of Sherley v Sebelius – a landmark lawsuit filed against the US’s state-funded National Institutes of Health (NIH) in 2009.
The case was brought by two scientists, Dr James Sherley and Dr Theresa Deisher, who opposed changes to NIH guidelines that expanded hESC research following an executive order by President Barack Obama. This order eased restrictions on hESC research imposed by the previous President, George W. Bush, but the pair, who both work with adult stem cells, argued the new guidelines violated the Dickey-Wicker Amendment. This is a 1996 law which bars the use of federal funds for ‘research in which a human embryo or embryos are destroyed’. Continue Reading »
Published: July 7, 2011 | Category:
News 
After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?
Hans Keirstead wakes up every morning at his home near Los Angeles and checks CNN. He’s looking for news about the first-ever human test of embryonic stem cells, launched in October by the biotechnology firm Geron. Mostly, he’s looking for bad news. “If someone dies, or is in pain, then it’s over,” he says, pushing a hand through his tawny hair. Keirstead, dressed in a loose linen shirt and wearing a thumb ring, is a biologist at the University of California, Irvine, who has variously been called the “rock star,” “miracle worker,” and “Pied Piper” of stem-cell science. Today he has a corner office in a new $67 million research center paid for in part by California voters, whom he helped persuade to vote for a $3 billion stem-cell spending plan in 2004 with a video of partially paralyzed rats walking again after stem-cell transplants performed in his laboratory. Continue Reading »
Published: July 5, 2011 | Category:
Answers As dental physicians, it is our duty to keep up with the most current technology available in order to afford our patients the best care possible. Recently, dental retrieval and storage of stem cells has become a topic of interest in the dental community. To help you understand this exciting advancement in the dental field, this article will answer some of the most commonly asked questions about stem cells. Continue Reading »
Published: June 24, 2011 | Category:
News A challenge to funding of human embryonic stem-cell studies should be dismissed after an appeals court found the government-backed research to be lawful, the Obama administration said.
The Justice Department in a filing today urged U.S. District Judge Royce Lamberth to end a lawsuit that seeks to block the U.S. Health and Human Services Department and the National Institutes of Health from spending federal funds on researching human embryonic stem-cells, known as hESC.
Last year, Lamberth temporarily barred U.S. agencies from funding human embryonic research, finding it likely violated a 1996 law called the Dickey-Wicker Amendment. The law prevents the government from spending money on research where a human embryo is damaged or destroyed. Continue Reading »
Loading ...